20 (AIDX) Other Non-Current Assets (2024 - 2026)

20 posted quarterly Other Non-Current Assets of $23057.0 for Q1 2026, little changed on a QoQ basis from $23057.0 in Q4 2025.

20 (AIDX) has 3 years of Other Non-Current Assets data on file, last reported at $23057.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $23057.0; the trailing twelve-month figure through Mar 2026 stood at $23057.0 (changed N/A YoY), and the FY2025 full-year result was $23057.0, down 85.76% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $23057.0, roughly flat from $23057.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $161957.0 in Q4 2024 and bottomed at $23057.0 in Q4 2025.
  • The 3-year median for Other Non-Current Assets is $23057.0 (2025), against an average of $69357.0.
  • Peak annual rise in Other Non-Current Assets reached 85.76% in 2025, while the deepest fall reached 85.76% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $161957.0 in 2024, then plunged by 85.76% to $23057.0 in 2025, then changed by 0.0% to $23057.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $23057.0 (Q1 2026), $23057.0 (Q4 2025), and $161957.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.17 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.04 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 738.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 140.49 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 285.90 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.25 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 211.40 Mn
10 20 - - 62,884.00 23,057.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23,057.00
Dec 31, 2025 1.51 Mn
Dec 31, 2024 161,957.00